If pharmaceutical TV ads were to be banned in the U.S., there would be significant questions about where that ad spend would go and how agencies would adapt.
Marketers indicated that pharma companies won't adjust their media plans until legally compelled, focusing instead on collaborating with lobbyists to navigate potential regulations.
Collection
[
|
...
]